» Articles » PMID: 14662844

Differential Effects of IL-1 Alpha and IL-1 Beta on Tumorigenicity Patterns and Invasiveness

Overview
Journal J Immunol
Date 2003 Dec 10
PMID 14662844
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we show that distinct compartmentalization patterns of the IL-1 molecules (IL-1alpha and IL-1beta), in the milieu of tumor cells that produce them, differentially affect the malignant process. Active forms of IL-1, namely precursor IL-1alpha (pIL-1alpha), mature IL-1beta (mIL-1beta), and mIL-1beta fused to a signal sequence (ssIL-1beta), were transfected into an established fibrosarcoma cell line, and tumorigenicity and antitumor immunity were assessed. Cell lines transfected with pIL-1alpha, which expresses IL-1alpha on the membrane, fail to develop local tumors and activate antitumor effector mechanisms, such as CTLs, NK cells, and high levels of IFN-gamma production. Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v. inoculation (experimental metastasis). In IL-1beta tumors, increased vascularity patterns were observed. No detectable antitumor effector mechanisms were observed in spleens of mice injected with IL-1beta transfectants, mock-transfected or wild-type fibrosarcoma cells. Moreover, in spleens of mice injected with IL-1beta transfectants, suppression of polyclonal mitogenic responses (proliferation, IFN-gamma and IL-2 production) to Con A was observed, suggesting the development of general anergy. Histologically, infiltrating mononuclear cells penetrating the tumor were seen at pIL-1alpha tumor sites, whereas in mIL-1beta and ssIL-1beta tumor sites such infiltrating cells do not penetrate inside the tumor. This is, to our knowledge, the first report on differential, nonredundant, in vivo effects of IL-1alpha and IL-1beta in malignant processes; IL-1alpha reduces tumorigenicity by inducing antitumor immunity, whereas IL-1beta promotes invasiveness, including tumor angiogenesis, and also induces immune suppression in the host.

Citing Articles

Association of Inflammation and Immune Cell Infiltration with Estrogen Receptor Alpha in an Estrogen and Ionizing Radiation-Induced Breast Cancer Model.

Koning T, Calaf G Int J Mol Sci. 2024; 25(16).

PMID: 39201290 PMC: 11354366. DOI: 10.3390/ijms25168604.


Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment.

Krishnamohan M, Kaplanov I, Maudi-Boker S, Yousef M, Machluf-Katz N, Cohen I Int J Mol Sci. 2024; 25(7).

PMID: 38612760 PMC: 11011794. DOI: 10.3390/ijms25073950.


Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A-2 in Human Prostate Cancer Cells.

Menchinskaya E, Dyshlovoy S, Venz S, Jacobsen C, Hauschild J, Rohlfing T Mar Drugs. 2024; 22(1).

PMID: 38248645 PMC: 10817243. DOI: 10.3390/md22010020.


High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.

Bjorner K, Chen W, Gannavarapu V, Axling F, Gulyas M, Halim M Ups J Med Sci. 2024; 28.

PMID: 38187473 PMC: 10770641. DOI: 10.48101/ujms.v128.10241.


Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.

Jhawar S, Wang S, Thandoni A, Bommareddy P, Newman J, Marzo A J Immunother Cancer. 2023; 11(7).

PMID: 37433716 PMC: 10347455. DOI: 10.1136/jitc-2023-006780.